期刊文献+

老年急性心肌梗死患者肿瘤坏死因子-α和白细胞介素-10的变化及辛伐他汀的干预作用 被引量:4

Changes in tumor necrosis factor-alpha and interleukin-10 in elderly patients with acute myocardial infarction and effect of simvastatin treatment
下载PDF
导出
摘要 目的 探讨老年人急性心肌梗死 (AMI)患者外周循环肿瘤坏死因子 α(TNF α)和白细胞介素 10 (IL 10 )的变化及辛伐他汀对TNF α和IL 10的作用。方法 测定 39例老年AMI患者 (AMI组 )、2 0例老年陈旧性心肌梗死 (OMI)患者 (OMI组 )及 2 0例正常老年人 (正常人组 )血清TNF α和IL 10浓度。 39例AMI患者入院后随机分为辛伐他汀组和对照组 ,治疗前、治疗后 1周和 6周测定血清TNF α和IL 10浓度。结果 AMI组TNF α、IL 10水平明显高于OMI组 ;OMI组TNF α水平明显高于正常人组 ;正常人组血清IL 10未检测到。辛伐他汀组和对照组经治疗后 1周、6周TNF α水平均显著下降 ,6周后辛伐他汀组TNF α水平显著低于对照组。辛伐他汀组和对照组IL 10水平 6周后均显著降低 ,但两组差异无显著性意义。结论 辛伐他汀具有降低AMI患者血清TNF α水平的作用 ,对IL Objective To investigate the changes of tumor necrosis factor alpha (TNF α) and interleukin 10 (IL 10) in elderly patients with acute myocardial infarction (AMI) and the effects of simvastatin.Methods Serum TNF α and IL 10 levels were measured with the method of ELISA in 39 AMI patients, 20 old myocardial infarction (OMI) patients and 20 normal controls.The 39 AMI patients were randomized into simvastatin group (n=20) and control group (n=19).Serum TNF α and IL 10 levels were examined before and after 1 week and 6 weeks of treatment.Results The serum levels of TNF α and IL 10 in the AMI group were significantly higher than those in the OMI group (P<0.0001). The serum level of TNF α in the OMI group was significantly higher than that in the normal controls (P<0.05). The serum IL 10 was not detected in the normal controls. The serum TNF α level was significantly decreased after 1 week(P<0.001) and 6 weeks (P< 0.0001 )of treatment in simvastatin group and control group.The serum TNF α level in the simvastatin group was significantly lower than that in the control group after 6 weeks(P<0.05)of treatment.The serum IL 10 level significantly decreased after 6 weeks of trearment(P<0.0001)in simvastatin group and control group. There was no significant difference between simvastatin group and control group in the serum IL 10 level after 6 weeks(P>0.05). Conclusions Simvastatin can modulate the level of serum TNF α in AMI patients,but can not modulate the level of serum IL 10.
出处 《中华老年心脑血管病杂志》 CAS 2003年第1期33-35,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 老年人 急性心肌梗死 肿瘤坏死因子-Α 白细胞介素-10 myocardial infarction tumor necrosis factor interleukin 10
  • 相关文献

参考文献8

  • 1Schwoartz G, Olsson A,Ezekowitz M, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes [J].JAMA, 2001,285 : 1711-1718.
  • 2Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction [J]. Circulation,1995,92 : 745-755.
  • 3Shibata M, Endo S, Inada K, et al. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction [J] .J Interferon Cytokine Res, 1997,17:145-150.
  • 4Zeguan Y, Basilia Z, Csaba S. Crucial role of endogenous intedeukin-10 production in myocardial ischemia / reperfusion injury [J] . Circulation, 2000,101 : 1019-1026.
  • 5傅广,赵水平,阳旭军.心力衰竭患者肿瘤坏死因子-α和白细胞介素-6的变化及氯沙坦的影响[J].中国循环杂志,2001,16(4):249-251. 被引量:18
  • 6Marie-Christine S, Jean D, Jacqueline B, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations [J]. J Thorac Cardiovasc Surg, 1996,111:545-553.
  • 7Domenico F, Sandrp P, Stefania B, et al. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia [J]. JACC,2000,36:427-431.
  • 8Michael W, Sinan P, Bruno M, et al. Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation [J]. J Am Coll Cardiol, 2001,38:814-818.

二级参考文献2

  • 1Han Y,Circulation Research,1999年,84卷,695页
  • 2Mann D L,Chest,1994年,105卷,897页

共引文献17

同被引文献55

  • 1袁侨英,覃数.辛伐他汀抑制大鼠急性心肌梗死后血管紧张素Ⅱ的生成和改善心室重塑的研究[J].重庆医学,2005,34(1):66-67. 被引量:8
  • 2Simes J, Furberg CD, Braunwald E, Davis BR, Ford I, Tonkin A, et al.Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels.The Prospective Pravastatin Pooling project.Eur Heart J, 2002, 23 (3):207-215
  • 3Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4S).Lancet, 1994, 344:1 383-389
  • 4Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS.Air Force/Texas Coronary Atherosclerosis Prevention Study.J Am Med Assoc, 1998, 279 (20):1 615-622
  • 5Plutzky J, Ridker PM.Statins for Stroke:The Second Story? Circulation, 2002, 103 (3):348-350
  • 6Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, et al.Effect of pravastatin on outcomes after cardiac transplantation.N Engl J Med, 1995, 333 (10):621-627
  • 7Wenke K, Meiser B, Thiery J, Nagel D, Scheidt WV, Steinbeck G, et al.Simvastatin reduces graft vessel disease and mortality after heart transplantation.Circulation, 1997, 96 (5):1 398-402
  • 8Strandberg TE, Vanhanen H, Tikkanen MJ.Effect of statins on C-reactive protein with coronary artery disease.Lancet, 1999, 353(9147):118-119
  • 9Rider PM, Rifai N, Pfeffer M, Sacks F, Braunwald E.For the cholesterol and recurrent event (CARE) investigators.Long-term effects of pravastatin on plasma concentration of C-reactive protein.Circulation, 1999, 100 (3):230-235
  • 10Albert MA, Staggers J, Chew P, Rider PM.The pravastatin inflammation CRP evaluation (PRINCE):rationale and design.Am Heart J, 2001, 141 (6):893-898

引证文献4

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部